Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

IPAR vs DORM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IPAR Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–5 Matrix Metrics)

IPAR Overall Winner 6-Pillar Tally: IPAR 3 – 3 DORM Matrix Metrics: IPAR 5 – 5 DORM

As of Nov 16, 2026, Interparfums, Inc. (IPAR) is the stronger overall head-to-head candidate over Dorman Products, Inc. New (DORM) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). IPAR carries a Unified Composite Score of 31.7/100 (SELL) at $133.94 (26.2x Forward P/E, 17.9% operating margin), whereas DORM carries 38.9/100 (SELL) at $131.38 (14.5x Forward P/E, 15.6% operating margin).

  • Composite vs. Pillar Nuance: While DORM currently prints a higher short-term Unified Composite Score (38.9/100 SELL vs. IPAR 31.7/100 SELL), IPAR captures the overall institutional head-to-head verdict (5–5 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (17.9% vs. 15.6% operating margin) and revenue trajectory (+0.0% vs. +3.3% YoY).
  • Defensive Composite Rating Caution: Although IPAR compares more favorably head-to-head, both IPAR (31.7/100 SELL) and DORM (38.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IPAR vs DORM
IPAR NASDAQ Head-to-Head Winner
Interparfums, Inc. Common Stock
Perfumes, Cosmetics & Other Toilet Preparations
$133.94
+0.43% 1D
Market Cap $4.2B
TTM Revenue $1.50B
Forward P/E 26.2x
Beta / 30D Vol 0.02β · 43% Vol
Unified Composite Score
31.7 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 69
RSI-14: 68.9 · SMA20: $123.59 · SMA50: $117.53
DORM NASDAQ
Dorman Products, Inc. New
Motor Vehicle Parts & Accessories
$131.38
-0.7% 1D
Market Cap $3.9B
TTM Revenue $2.17B
Forward P/E 14.5x
Beta / 30D Vol 0.70β · 34% Vol
Unified Composite Score
38.9 / 100 SELL
Tech 25.0 Fund 42.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 50.3 · SMA20: $132.25 · SMA50: $127.04

6-Pillar Scorecard Institutional Category Breakdown (IPAR 3 – 3 DORM)

Columns: Metric · IPAR · DORM
1. Valuation Multiples DORM
Forward P/E 26.2x 14.5x
Trailing P/E 24.6x 19.7x
PEG Ratio 3.20x 1.17x
EV / Revenue 2.8x 2.0x
2. Growth & Scale DORM
Revenue Growth (YoY) +0.0% +3.3%
Earnings Growth (YoY) +3.9% -20.2%
TTM Revenue (USD) $1.50B $2.17B
Market Cap $4.2B $3.9B
3. Profitability & Quality IPAR
Gross Margin 59.8% 41.1%
Operating Margin 17.9% 15.6%
Net Profit Margin 11.3% 9.3%
Return on Equity (ROE) 19.0% 13.3%
4. Balance Sheet & Cash Flow IPAR
Cash Generation (TTM) $293M EBITDA $269M
Cash Flow Margin 19.5% EBITDA Mgn 12.4%
Net Cash / Leverage $27.43 Book/Sh · 19.0% ROE $356M Net Debt (0.33x D/E)
Dividend Yield 2.40% None (0.00%)
5. Options & Positioning DORM
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 41.0% (2nd %ile) 37.8% (26th %ile)
Put/Call OI Skew N/A 1.00x (Balanced)
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat IPAR
OpEx & R&D Intensity 41.9% of Rev ($629M) 25.5% of Rev ($554M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Household & Personal Products Operator Auto Parts Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IPAR (5) vs DORM (5)
Institutional Metric IPAR DORM Criterion Row Edge
Market Capitalization
Scale
$4.2B $3.9B Larger Scale IPAR
Trailing P/E Ratio
Valuation
24.6x 19.7x Lower Multiple DORM
Forward P/E Ratio
Valuation
26.2x 14.5x Lower Multiple DORM
Revenue Growth (YoY)
Growth
+0.0% +3.3% Higher Growth DORM
Operating Margin (TTM)
Profitability
17.9% 15.6% Higher Margin IPAR
Net Profit Margin
Profitability
11.3% 9.3% Higher Margin IPAR
Return on Equity (ROE)
Capital Efficiency
19.0% 13.3% Higher ROE IPAR
52-Week Range Position
Momentum
93% ($77–$138) 58% ($98–$155) Stronger Trend IPAR
Beta / 30D Volatility
Risk Regime
0.02β · 43% Vol 0.70β · 34% Vol Lower Realized Risk DORM
Unified Institutional Score
Composite Signal
31.7 / 100 (SELL) 38.9 / 100 (SELL) Higher Composite DORM
Trailing 12M Revenue (USD)
Operating Scale
$1.50B $2.17B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
59.8% 41.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.20x PEG · 2.8x EV/Rev 1.17x PEG · 2.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$293M EBITDA ($27.43 Book/Sh · 19.0% ROE) $269M ($356M Net Debt (0.33x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IPAR +9.72 pp
IPAR: +15.77% · DORM: +6.05%
3M Horizon IPAR +19.13 pp
IPAR: +18.05% · DORM: -1.08%
6M Horizon IPAR +39.17 pp
IPAR: +53.32% · DORM: +14.15%
1Y Horizon IPAR +55.42 pp
IPAR: +53.11% · DORM: -2.31%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPAR vs DORM. Trailing 12-month operating profitability (IPAR 17.9% vs DORM 15.6%) and valuation multiples (IPAR 26.2x vs DORM 14.5x Forward P/E) are benchmarked directly in Pillar 4 below.

IPAR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.50B
Gross Margin59.8%
Op. Margin17.9%
ROE / Fwd P/E19.0% · 26.2x
DORM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.17B
Gross Margin41.1%
Op. Margin15.6%
ROE / Fwd P/E13.3% · 14.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IPAR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 41.0%
IV Percentile 2nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IPAR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DORM CONSOLIDATION
97d in phase · OBV DISTRIBUTION
Current IV 37.8%
IV Percentile 26th %ile
Put/Call OI Skew 1.00x (Balanced)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact DORM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IPAR Moat Profile Scale & Operating Efficiency Moat
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $4.2B market capitalization and 17.9% operating margin.
OpEx & R&D Reinvestment 41.9% of Rev ($629M)
90D Engineering Disclosures 0 Published
DORM Moat Profile Scale & Operating Efficiency Moat
Auto Parts Operator
Competes within the Auto Parts value chain with $3.9B market capitalization and 15.6% operating margin.
OpEx & R&D Reinvestment 25.5% of Rev ($554M)
90D Engineering Disclosures 0 Published

Investor FAQ IPAR vs DORM Key Questions & Quantitative Answers

As of Nov 16, 2026, Interparfums, Inc. (IPAR) is the stronger overall head-to-head candidate over Dorman Products, Inc. New (DORM) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). IPAR carries a Unified Composite Score of 31.7/100 (SELL) at $133.94 (26.2x Forward P/E, 17.9% operating margin), whereas DORM carries 38.9/100 (SELL) at $131.38 (14.5x Forward P/E, 15.6% operating margin). Composite vs. Pillar Nuance: While DORM currently prints a higher short-term Unified Composite Score (38.9/100 SELL vs. IPAR 31.7/100 SELL), IPAR captures the overall institutional head-to-head verdict (5–5 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (17.9% vs. 15.6% operating margin) and revenue trajectory (+0.0% vs. +3.3% YoY). Defensive Composite Rating Caution: Although IPAR compares more favorably head-to-head, both IPAR (31.7/100 SELL) and DORM (38.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

DORM leads the Growth & Scale pillar: IPAR posts +0.0% YoY revenue growth and +3.9% YoY earnings growth on $1.50B TTM revenue (59.8% gross margin, 17.9% operating margin), compared with DORM at +3.3% YoY revenue growth and -20.2% YoY earnings growth on $2.17B TTM revenue (41.1% gross margin, 15.6% operating margin). On trailing 12-month operating scale, IPAR generates $1.50B in USD-normalized revenue versus $2.17B for DORM. In operating R&D and SG&A reinvestment, IPAR deploys 41.9% of Rev ($629M) (0 90-day corporate R&D disclosures) versus 25.5% of Rev ($554M) (0 disclosures) for DORM.

DORM screens cheaper on headline valuation multiples. IPAR trades at 26.2x Forward P/E, 24.6x Trailing P/E, 3.20x PEG, and 2.8x EV/Revenue (19.5% EBITDA margin), whereas DORM trades at 14.5x Forward P/E, 19.7x Trailing P/E, 1.17x PEG, and 2.0x EV/Revenue (12.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IPAR (19.0% ROE) versus DORM (13.3% ROE) capital efficiency.

In options market volatility and institutional positioning, IPAR carries 41.0% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 43% Vol realized risk). By comparison, DORM carries 37.8% implied volatility (26th %ile, Balanced (25th–60th %ile)), a 1.00x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.70β · 34% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.